We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Novozymes AS (NZYM-B) Ser B DKK2

Sell:453.00 DKK Buy:453.50 DKK Change: 6.60 DKK (1.48%)
Market closed |  Prices as at close on 22 October 2021 | Switch to live prices |
Sell:453.00 DKK
Buy:453.50 DKK
Change: 6.60 DKK (1.48%)
Market closed |  Prices as at close on 22 October 2021 | Switch to live prices |
Sell:453.00 DKK
Buy:453.50 DKK
Change: 6.60 DKK (1.48%)
Market closed |  Prices as at close on 22 October 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.

Contact details

Krogshoejvej 36
+45 (44) 460000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
102.03 billion DKK
Shares in issue:
277.47 million
Specialty Chemicals
Copenhagen Stock Exchange
Danish Krone

Key personnel

  • Joergen Buhl Rasmussen
    Independent Chairman of the Board
  • Ester Baiget
    President, Chief Executive Officer
  • Cees de Jong
    Independent Vice Chairman of the Board
  • Lars Green
    Chief Financial Officer, Executive Vice President - Finance, IT & Legal
  • Graziela dos Santos Malucelli
    Chief Operating Officer, Executive Vice President, Operations, Supply & Quality
  • Claus Fuglsang
    Executive Vice President - Research & Development, Chief Scientific Officer
  • Morten Rasmussen
    Executive Vice President - People, Sustainability and Brand
  • Amy Byrick
    Executive Vice President - Strategy and Business Transformation
  • Anders Lund
    Executive Vice President, Consumer Biosolutions
  • Tina Sejersgaard Fanoe
    Executive Vice President, Agriculture & Industrial Biosolutions

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.